eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Symptom | C0007222|cardiovascular disease |
| Sentences | 57 |
| PubMedID- 21679922 | Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 22321049 | Metabolic disorders such as arterial hypertension (ah), hypercholesterolemia, diabetes mellitus (dm), high triglycerides (tg), abdominal obesity, and metabolic syndrome (mets) are associated with cardiovascular disease (cvd) and cvd-related mortality. |
| PubMedID- 24498934 | Relation between ev-markers and metabolic syndrome in patients with manifest cardiovascular disease. |
| PubMedID- 23199128 | In this review, we first describe the population trend in the degree of obesity as measured by the body mass index (bmi), and review prospective cohort studies that reported associations of obesity measures and metabolic syndrome (mets) with cardiovascular diseases (cvd) in japanese. |
| PubMedID- 22205060 | The worldwide obesity epidemic has brought to the author's attention the cardiometabolic risk factors and cardiovascular disease associated with the metabolic syndrome. |
| PubMedID- 25633268 | Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd). |
| PubMedID- 21841320 | Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd). |
| PubMedID- 24553695 | Dietary echium oil increases long-chain n-3 pufas, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome. |
| PubMedID- 24844874 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 22417140 | Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease. |
| PubMedID- 21766575 | The association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study. |
| PubMedID- 24705461 | Aids-related lymphoma (arl), metabolic syndromes (including cardiovascular diseases, cvds; atherosclerosis and other lipid disorders), and hiv-associated dementia (had) – can be considered as all macrophage-mediated disorders in which nef is an unquestioned key factor . |
| PubMedID- 26491696 | In particular, sodium reabsorption is regulated by various transporters along the nephron and to elucidate the mechanism of its regulation is important because excess renal sodium retention causes hypertension in metabolic syndrome that leads to cardiovascular disease 1. |
| PubMedID- 22123633 | There seems to be an inverse relation between 25(oh)d serum concentrations and cardiovascular diseases, some components of the metabolic syndrome, and physical fitness. |
| PubMedID- 24278817 | We must consider that beyond the dyslipidemia, hypertension, atherosclerosis, and progression to type 2 diabetes, cerebral vascular disease, and cardiovascular disease, the consequences of cardiometabolic syndrome include type 3 diabetes, sleep apnea, malignancies, erectile dys-function, nonalcoholic fatty liver disease, end-stage renal disease, and osteoporosis. |
| PubMedID- 25916279 | Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome. |
| PubMedID- 19720470 | Insulin resistance (ir), which is a major component of metabolic syndrome (mets), is associated with cardiovascular disease risk. |
| PubMedID- 24926685 | Nafld is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. |
| PubMedID- 22682107 | Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit. |
| PubMedID- 23334870 | This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting. |
| PubMedID- 23873328 | Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure. |
| PubMedID- 22916265 | The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity. |
| PubMedID- 21654497 | In the univariate analysis, variables significantly associated with hypertension were age, waist circumference, established cardiovascular disease, family history of hypertension, lipoatrophy, metabolic syndrome, duration of infection, cd4 nadir, hiv rna <50 copies/ml, and antiretroviral treatment. |
| PubMedID- 21122628 | Background: metabolic syndrome is associated with increased cardiovascular disease (cvd) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (ldl-c). |
| PubMedID- 24716162 | It is also strongly related to other pathological conditions, including obesity, diabetes, cardiovascular diseases, and symptoms of metabolic syndrome. |
| PubMedID- 22417460 | High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. |
| PubMedID- 20940070 | Analysis results on population attributable risks showed that about a quarter of total diabetes occurrence and more than 10% of cardiovascular disease was attributable to the metabolic syndrome. |
| PubMedID- 21466628 | Based on the increased cardiovascular disease risk of the metabolic syndrome, which is similar to stage 1 hypertension, both lifestyle modification and arb therapy are justifiable. |
| PubMedID- 22760893 | Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases. |
| PubMedID- 24624345 | Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome , cerebrovascular disease 6, obesity, diabetes, hypertriglyceridemia, and hypertension. |
| PubMedID- 19958158 | Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress. |
| PubMedID- 25248654 | Studies linking low testosterone to the metabolic syndrome (with its sequelae cardiovascular disease and diabetes mellitus) and inflammation have been predominantly performed in elderly men. |
| PubMedID- 23524050 | The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease. |
| PubMedID- 21130454 | Given the frequent concordance of metabolic diseases including diabetes, obesity, and metabolic syndrome with cardiovascular diseases associated with hyperlipidemia, it is important to understand the potential metabolic risks and benefits of therapies with distinct statins. |
| PubMedID- 22121272 | Although metabolic syndrome leads to cardiovascular disease, psoriasis might be an independent risk factor for hypertension and cardiovascular disease even after correction for metabolic syndrome components. |
| PubMedID- 23323622 | Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. |
| PubMedID- 23961478 | For high-risk patients, ldl-c treatment goal was ldl <100 mg/dl but an ldl-c goal of <70 mg/dl was considered a therapeutic option for very high risk patients who had recent heart attacks, cardiovascular disease with diabetes, metabolic syndrome, or severe/poorly controlled risk factors. |
| PubMedID- 20671994 | On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity . |
| PubMedID- 24393433 | Objective: metabolic syndrome (mets) is associated with cardiovascular disease (cvd). |
| PubMedID- 20488778 | In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 24708775 | In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia . |
| PubMedID- 25918936 | The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation . |
| PubMedID- 20823276 | Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 20004035 | Aims: to compare the cardiovascular disease (cvd) risk associated with the metabolic syndrome (mets) and dysglycemia, independent of each other during a median follow-up of 6.7 years. |
| PubMedID- 21516134 | Although several studies have reported that the chemerin/chemr23 axis is strongly associated with cardiovascular disease and aspects of metabolic syndrome11, 26, 27, there was no direct evidence for the role of the chemerin/chemr23 axis in maintaining endothelial function. |
| PubMedID- 24453423 | Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us , ethnicity did not impact the il-6-endothelial activation relationship in the present investigation. |
| PubMedID- 20349347 | The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities. |
| PubMedID- 22877354 | Data from a community based study was used to assess the risk for type 2 diabetes, cardiovascular disease and prevalence of metabolic syndrome in middle-aged men. |
Page: 1 2